Skip to main content

GE HealthCare

Emerging Technologies
By Jessica Hagen | 01:08 pm | February 05, 2026
Sergio Calvo, general manager of theranostics at GE HealthCare, joins MobiHealthNews to discuss how combining molecular imaging and targeted therapy is personalizing cancer care.
By Jessica Hagen | 12:55 pm | January 02, 2026
Industry voices discuss where AI will make the biggest impact in the healthcare workforce and which positions may be affected by automation.
By Jessica Hagen | 11:57 am | December 12, 2025
This year was marked by shocking events alongside soaring company valuations, policy transformation, rapid AI adoption and landmark investments in women’s health.
By Jessica Hagen | 01:56 pm | December 04, 2025
Industry leaders say 2025 marked AI’s shift from hype to practical impact, though the technology remains unready for full-scale adoption and ongoing concerns about ethics and bias persist.
By Jessica Hagen | 02:31 pm | March 21, 2025
GE HealthCare's global product marketing director, Peter Eggleston, sat down with MobiHealthNews at HIMSS25 to discuss the company's Genesis offering.
By Jessica Hagen | 03:38 pm | January 17, 2025
Abu Mirza, GE HealthCare's global SVP of digital products and engineering, joined MobiHealthNews during JPM to discuss the company's efforts to leverage AI to improve care efficiency.
By Jessica Hagen | 09:00 am | December 31, 2024
AI will transform healthcare with advances in multimodal technology, diagnostic imaging and automation, but its success depends on trust and seamless integration into workflows.
By Jessica Hagen | 01:30 pm | December 19, 2024
Digital health leaders reveal the year's noteworthy events, including the rise in AI valuations, spike in demand for emergency contraception, realizations pertaining to LLMs and more.
By Jessica Hagen | 01:33 pm | December 12, 2024
Industry executives share their thoughts on the year's digital health developments - from an increased focus on women’s health to the rise of generative AI.
By Anthony Vecchione | 01:24 pm | December 02, 2024
The deal boosts GE HealthCare's pharma diagnostics sector and signifies its dedication to molecular imaging.